Description: NeuroScientific Biopharmaceuticals Ltd is an Australia-based pharmaceutical company. The Company develops peptide-based drugs that target neurodegenerative conditions. The Company’s product portfolio consists of EmtinB, 15mS.A, and other Emtin peptides. EmtinB is the Company’s lead therapeutic peptide candidate targeting Alzheimer's disease. 15mS.A. is a diagnostic peptide foe early-stage Alzheimer’s disease. Other Emtin peptides include EmtinAc, EmtinAn, and EmtinBn that demonstrates similar therapeutic properties as EmtinB.
Home Page: www.neuroscientific.com
NSB Technical Analysis
C/O John Nuveen & Co Inc
,
Phone:
800-257-8787
Officers
| Name | Title |
|---|---|
| Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC | Interim CEO & CHairman |
| Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. | CFO & Company Sec. |
| Dougal Thring | Chief Operating Officer |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.0289 |
| Price-to-Sales TTM: | 314.4018 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |